Dr. Michael L. Durando, M.D.-PH.D.
Hematology & Oncology (Hematology & Oncology Physician)
At a glance
- Medical school
- University of North Carolina at Chapel Hill School of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: University of North Carolina at Chapel Hill School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
AZ license 61229 · ID license 4161474 · UT license 12243243-1205 -
Internal Medicine Physician
PA license MD467345 -
Medical Oncology Physician
UT license 12243243
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Eastern Idaho Regional Medical Center Idaho Falls, ID
- Gila Regional Medical Center Silver City, NM
Medical groups
- Gila Regional Medical Center (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $134 in total to this clinician.
| Karyopharm Therapeutics Inc. | $134 |
|---|
| Food and Beverage | $134 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.